Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NPCE
#2869
Neuropace, Inc. - Common Stock
15.8
4
USD
-0.07%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-7.48%
Monthly Change
+2.19%
6 month change
-8.65%
Year Change
+49.72%
Previous Close
17.1
2
Open
15.8
4
Low
15.8
4
High
15.8
4
Volume
38
Markets
US Stock Market
Healthcare
Medical Devices
NPCE
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Current
Key stats
Total common shares outstanding
32.8 M
33.08 M
33.31 M
33.67 M
34.09 M
34.09 M
Valuation ratios
Enterprise value
435.86 M
404.29 M
381.5 M
557.01 M
492.57 M
618.04 M
Price to earnings ratio
-14.99
-13.59
-13.93
-23.39
-20.23
-25.89
Price to sales ratio
4.3
3.82
3.41
5.05
4.37
5.59
Price to cash flow ratio
20.53
21.14
19.56
-45.91
-46.69
-59.75
Price to book ratio
7.09
5.6
4.64
26.55
6.09
7.79
Enterprise value to EBITDA ratio
-23.11
-20.78
-21.44
-35.11
-26.67
-38.02
Profitability ratios
Return on assets %
-0.06
-0.08
-0.03
-0.03
-0.07
-0.07
Return on equity %
-0.27
-0.45
-0.19
-0.14
-0.46
-0.46
Return on invested capital %
-67.6
-92.36
-34.72
-23.86
-74.3
-74.3
Gross margin %
76.99
77.09
77.39
77.4
81.78
81.78
Operating margin %
-22.85
-29.01
-9.51
-6.65
-25.23
-25.23
EBITDA margin %
-22.42
-28.35
-8.88
-6.45
-24.65
-24.65
Net margin %
-29.25
-36.78
-12.78
-10.26
-30.31
-30.31
Liquidity ratios
Quick ratio
5.7
4.51
3.94
4.33
4.35
4.35
Current ratio
6.63
5.47
4.86
5.28
5.38
5.38
Inventory turnover
0.38
0.33
0.36
0.34
0.24
0.24
Asset turnover
0.22
0.22
0.26
0.25
0.22
0.22
Solvency ratios
Debt to assets ratio
0.54
0.55
0.55
0.56
0.6
0.6
Debt to equity ratio
2.46
3.02
3.17
3.09
4.08
4.08
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.24
-0.06
-0.06
0.02
-0.17
-0.28
EBIT per share
-0.16
-0.21
-0.08
-0.05
-0.17
-0.51
EBITDA per share
-0.16
-0.2
-0.07
-0.05
-0.16
-0.49
Total debt per share
1.9
1.78
1.77
1.8
1.75
1.75
Cash per share
2.11
1.89
1.81
1.87
1.6
1.6
Net current asset value per share
3.1
2.85
2.88
2.87
2.58
2.58
Tangible book value per share
0.77
0.59
0.56
0.58
0.43
0.43
Working capital per share
2.63
2.33
2.29
2.33
2.1
2.1
Book value per share
0.77
0.59
0.56
0.58
0.43
0.43
News
Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 27.88%: Here's is How to Trade
NeuroPace (NPCE) Down 0.6% Since Last Earnings Report: Can It Rebound?
Here's Why You Should Add NeuroPace Stock to Your Portfolio Now
NPCE Receives FDA Approval for AI-Powered ECoG Assistant for Epilepsy
Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?
NPCE Explains How NeuroPace's RNS System Makes Money
NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care
NPCE Stock Gains on Q1 Earnings & Revenue Beat, 2026 Outlook Raised
NeuroPace, Inc. (NPCE) Q1 2026 Earnings Call Transcript
NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates
BSX Q1 Neuromodulation Sales Rise 15% Y/Y: What Lies Behind the Growth?
NeuroPace (NPCE) Moves 6.3% Higher: Will This Strength Last?